imipramine has been researched along with Cortical Lewy Body Disease in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, C | 1 |
| Johnson, M | 1 |
| Piggott, M | 1 |
| Perry, R | 1 |
| O'Brien, J | 1 |
| Rowan, E | 1 |
| Perry, E | 1 |
| Lantos, P | 1 |
| Cairns, N | 1 |
| Holmes, C | 1 |
1 other study available for imipramine and Cortical Lewy Body Disease
| Article | Year |
|---|---|
A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Autoradiography; Binding Sites; Carrier Proteins; Depressive Disorder; Fema | 2002 |